Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website; (3) the federal government Internet portal; or (4) a web search conducted using a commercial search engine such as
Accession Number ADA564153
Title Discovery and Testing of Ricin Therapeutics.
Publication Date Jun 2012
Media Count 13p
Personal Author D. Tortorella V. Redmann
Abstract Ricin is an extremely potent A-B toxin that is transported from the cell surface to the cytosol where it inactivates ribosomes leading to cell death. Ricin access to the cytosol is dependent on its transport from the cell surface to the ER lumen. We have established a ricin A chain dislocation assay using enzymatic attenuated ricin A chain molecules (RTAE177D and RTAdelta). The ricin A chains undergoes a rapid transport across the ER membrane and is eventually degraded by the proteasome. The instability of ricin A chain was developed into a high-throughput screen to identify chemicals that block ricin transport. A green fluorescent protein (GFP) ricin chimera was created to screen chemical libraries in ricin dislocation inhibitors. Using a high content screen, we have screened a small bioactive FDA -approved chemical library consisting of 2080 compounds and >35,000 compounds from a large chemical library referred to as L1. Presently, we have identified at least eight diverse family of compounds that increased the stability of the ricin-GFP chimera. Secondary assays have confirmed the stability of ricin and other cellular degradation substrates. The data demonstrate that these chemicals could be used to block ricin and may be effective against other pathogens and human diseases.
Keywords Cell death
Chemical inhibitors
Er lumen
Fluorescent-based cell assay
High-content screen
Pathogenic microorganisms
Ricin toxin
Small weight compounds
Toxins and antitoxins

Source Agency Non Paid ADAS
NTIS Subject Category 57E - Clinical Medicine
74D - Chemical, Biological, & Radiological Warfare
Corporate Author Mount Sinai School of Medicine, New York.
Document Type Technical report
Title Note Final rept. 17 May 2010-16 May 2012.
NTIS Issue Number 1302
Contract Number W81XWH-10-2-0048

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader